Mango Sciences Inc. Partners with ImmunoAdoptive Cell Therapy to Improve Access to NexCAR19 in India
Key Highlights: Implication: This financing model slashes NexCAR19’s effective cost by 30-40%, challenging global CAR-T players like Novartis/Kite while accelerating adoption in Tier...
